Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Primary central nervous system lymphoma with initial spinal cord involvement (PCNSL-SC) is a rare entity: 4 case reports and review of literature.
Harlay V, Campello C, Bequet C, Petrirena G, Barrie M, Appay R, Arnoux I, Loosveld M, Testud B, Bertucci A, Tabouret E, Chinot O. Harlay V, et al. Rev Neurol (Paris). 2024 Mar;180(3):224-229. doi: 10.1016/j.neurol.2023.10.003. Epub 2023 Oct 26. Rev Neurol (Paris). 2024. PMID: 39300797 Review. No abstract available.
REVOLUMAB: A phase II trial of nivolumab in recurrent IDH mutant high-grade gliomas.
Picca A, Touat M, Belin L, Gourmelon C, Harlay V, Cuzzubbo S, Cohen-Jonathan Moyal E, Bronnimann C, Di Stefano AL, Laurent I, Lerond J, Carpentier C, Bielle F, Ducray F, Dehais C; POLA Network. Picca A, et al. Among authors: harlay v. Eur J Cancer. 2024 May;202:114034. doi: 10.1016/j.ejca.2024.114034. Epub 2024 Mar 22. Eur J Cancer. 2024. PMID: 38537315 Clinical Trial.
Radio-chemotherapy feasibility for biopsy-only unresectable IDH wild-type glioblastomas (BO-GBM).
Harlay V, Appay R, Bequet C, Petrirena G, Campello C, Barrié M, Autran D, Graillon T, Boissonneau S, Dufour H, Figarella-Branger D, Padovani L, Barlier A, Nanni I, Tabouret E, Chinot O. Harlay V, et al. Neurooncol Pract. 2023 May 30;10(6):536-543. doi: 10.1093/nop/npad028. eCollection 2023 Dec. Neurooncol Pract. 2023. PMID: 38009116 Free PMC article.
SARS-CoV-2 infection in patients with primary central nervous system lymphoma in the vaccination era.
Laurenge A, Ursu R, Tabouret E, Harlay V, Ahle G, Choquet S, Soussain C, Moluçon-Chabrot C, Mathon B, Mokhtari K, Pourcher V, Nichelli L, Marot S, Touat M, Hoang-Xuan K, Houillier C. Laurenge A, et al. Among authors: harlay v. Leuk Lymphoma. 2023 Jan;64(1):221-224. doi: 10.1080/10428194.2022.2131420. Epub 2022 Nov 1. Leuk Lymphoma. 2023. PMID: 36318828 No abstract available.
11 results